Augusto Consoli

Specialization: Psychiatrist
41 years of experience
Speaks:
English, Italian
Online consultations: available
Workplace: Italy, Bologna, Lucia Magnani Health Clinic
Key contributor to the LEVOPROACT study on levomethadone.
Dr. Augusto Consoli is a psychiatrist at Lucia Magnani Health Clinic in Bologna. He specializes in psychotherapy and opioid addiction treatment. Dr. Consoli was a key contributor to the LEVOPROACT study. This research advanced the understanding of levomethadone safety for opioid maintenance therapy.
- Treats complex conditions like drug addiction, schizophrenia, and bipolar disorder.
- Developed clinical data on reducing opioid cravings and drug use.
- Collaborated with multiple medical research centers across Italy.
- Practice is based at a boutique clinic recognized by Bookimed for patient assistance.

Online consultation with Augusto Consoli

Convenient and easy

100% secure and confidential

Price on request

Doctor's services

How are we doing?

1 of 3

Information about this doctor is full and clear

Strongly disagree

Strongly agree

Qualifications

Dr. Augusto Consoli is a psychiatrist and psychologist specializing in addiction treatment and psychotherapy at Lucia Magnani Health Clinic. He is a key contributor to the LEVOPROACT study, which advanced safety standards for opioid maintenance therapy. Dr. Consoli participates in research to improve treatments for complex mental health and substance abuse disorders.

Specialization and Therapeutic Focus

The doctor treats patients with depression, drug addiction, schizophrenia, and bipolar affective disorder. He uses specialized psychotherapy techniques to treat chemical dependencies and mental health crises. Dr. Consoli also conducts alcohol abuse examinations to develop recovery plans. These plans help patients manage their symptoms and long-term sobriety.

Drug Addiction Research and Outcomes

Dr. Consoli participated in the LEVOPROACT prospective study across Italy. This research evaluated the safety and effectiveness of levomethadone – a medication used to reduce withdrawal symptoms – for opioid maintenance. He helped demonstrate that this therapy has a favorable risk–to–benefit ratio. These findings specifically showed that the treatment reduces drug cravings. Additionally, the study proved the medication's safety regarding heart rhythm and the QT interval – a measurement of the heart's electrical cycle.

Study Responsibilities

During the LEVOPROACT study, the doctor performed the following:

Contributed to the design and data collection for the research.
Collaborated with principal investigators from multiple medical centers across Italy.
Participated in preparing, editing, and approving the final research manuscripts.
Interpreted clinical data to improve patient safety during addiction therapy.

Professional Experience

Psychiatrist and Psychologist – Lucia Magnani Health Clinic, Italy.
Clinical Researcher – LEVOPROACT Multi–center Study Group, Italy.